DFX Intelligence

Data Factory

Crystalys Therapeutics

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:91426cbb-ac48-4fc7-ac2f-0d559fdd5be7

Data as of Sep 16, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 18, 2026, 11:36 PM UTC and rebuilt at most every 15 minutes.

Relationships: 3
Dated events: 0
On other graphs: 1
Observed: Sep 15, 2026 to Sep 16, 2026
2 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Crystalys Therapeutics

Venture-backed company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Owners: Soleus Capital Management, L.P., SR One Capital Management, LP, Frazier Life Sciences Management, LP
Owned since: Jul 22, 2026
Add-ons on file: 0add-on transactions linked to this company on the graph
Transactions: 0
Investors: 3

Investors

Investor	Class	Role	Control	Invested	Status
Soleus Capital Management, L.P.	Buyout	minority	minority	Jul 22, 2026	active
SR One Capital Management, LP	Buyout	unknown	unknown	n/a	active
Frazier Life Sciences Management, LP	Candidate PE	unknown	unknown	n/a	unknown

Relationships

Invested in (3)

← Soleus Capital Management, L.P.Firmminority
Jul 22, 2026 to presentfactDFX's own graph
← Frazier Life Sciences Management, LPFirmunknown
factThe subject's own site
← SR One Capital Management, LPFirmunknown
factThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Private Equity
Canonical id: dfx:pe:91426cbb-ac48-4fc7-ac2f-0d559fdd5be7
First observed: Sep 15, 2026
Last observed: Sep 16, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.